Boston Scientific completes acquisition of Axonics, Inc. to expand into sacral neuromodulation
Acquiring Company
Boston Scientific
Acquired Company
Axonics
Description
Boston Scientific Corporation has successfully closed its acquisition of Axonics, Inc., a medical technology company specializing in devices to treat urinary and bowel dysfunction. This acquisition allows Boston Scientific to expand into sacral neuromodulation, a high-growth adjacency for their Urology business, and to provide a comprehensive product portfolio to patients seeking tailored treatment options for incontinence.
Quick answer
Boston Scientific is acquiring Axonics, announced November 15, 2024. Boston Scientific is based in Marlborough, Massachusetts, United States.
- How much did Boston Scientific pay for Axonics?
- The deal value was not disclosed.
- What does Boston Scientific do?
- Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world.
- Where are Boston Scientific and Axonics based?
- Boston Scientific is based in Marlborough, Massachusetts, United States. Axonics is based in Irvine, California, United States.
- Who are the decision-makers at Boston Scientific?
- Fundz holds 2 contacts at Boston Scientific. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Medical and Medical Device
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- H.B. Fuller Company signs agreements to acquire Medifill Ltd. and GEM S.r.l. to expand its Medical Adhesive Technologies business (December 2, 2024)
- Medtronic completes acquisition of Fortimedix to enhance its surgical technology portfolio (November 22, 2024)
- Trinity Biotech plc acquires EpiCapture Limited to expand into oncology diagnostics (October 25, 2024)
- OraSure Technologies completes acquisition of Sherlock Biosciences, Inc. to expand its innovation pipeline in molecular testing market (December 19, 2024)
- StatLab Medical Products completes acquisition of Especialidades Médicas Myr, S.L. to expand global reach (December 18, 2024)
- Novo Holdings completes acquisition of Catalent, Inc. (December 18, 2024)
Who to call at Boston Scientific, and when
When Boston Scientific changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Boston Scientific raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Boston Scientific, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Boston Scientific. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Boston Scientific makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Axonics?
Axonics was acquired by Boston Scientific, based in Marlborough. The deal was reported on November 15, 2024. Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. Boston Scientific is publicly traded (BSX) and operates in Manufacturing.
When did Boston Scientific acquire Axonics?
Boston Scientific's acquisition of Axonics was reported on November 15, 2024. Boston Scientific Corporation has successfully closed its acquisition of Axonics, Inc., a medical technology company specializing in devices to treat urinary and bowel dysfunction. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Axonics do?
Axonics® is dedicated to improving the quality of life of people suffering from bladder and bowel dysfunction, conditions that impact the lives of tens of millions of adults globally. It is privately held, operating in Manufacturing, and is based in Irvine.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.